kabutan

Fuso Pharmaceutical Industries,Ltd.(4538) Summary

4538
TSE Prime
Fuso Pharmaceutical Industries,Ltd.
2,233
JPY
+31
(+1.41%)
Dec 12, 3:30 pm JST
14.33
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
8.2
PBR
0.56
Yield
4.03%
Margin Trading Ratio
22.59
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
2,225 JPY 14.30 USD
Previous Close Dec 11
2,202 JPY 14.10 USD
High Dec 12, 9:21 am
2,234 JPY 14.35 USD
Low Dec 12, 1:23 pm
2,218 JPY 14.24 USD
Volume
28,300
Trading Value
0.06B JPY 0.40M USD
VWAP
2226.08 JPY 14.29 USD
Minimum Trading Value
223,300 JPY 1,433 USD
Market Cap
0.02T JPY 0.14B USD
Number of Trades
102
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
Mid
1-Year Average
86
1-Year High Feb 10, 2025
818
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 7,700 26,000 3.38
Nov 28, 2025 8,200 21,900 2.67
Nov 21, 2025 7,500 24,300 3.24
Nov 14, 2025 6,100 24,300 3.98
Nov 7, 2025 4,300 25,700 5.98
Company Profile
Fuso Pharmaceutical Industries, Ltd. is a leading manufacturer of artificial kidney dialysis solutions and holds a high market share in blood-related pharmaceuticals. The company also produces medical devices and generic drugs.
Sector
Pharmaceuticals
Fuso Pharmaceutical Industries, Ltd. primarily engages in the manufacture and sale of medical pharmaceuticals and medical equipment. In the field of medical pharmaceuticals, the company focuses on the production and distribution of injectable solutions, particularly infusion fluids, and artificial kidney dialysis agents. Additionally, the company undertakes contract manufacturing of pharmaceuticals and develops generic drugs. Beyond its pharmaceutical operations, Fuso has established a presence in the real estate sector through property leasing. By encompassing a wide range of activities from manufacturing to sales, primarily in the medical field, Fuso has built a diversified revenue structure.